-
Signature
-
/s/ Danielle V. Holland, attorney in fact
-
Stock symbol
-
AVEO
-
Transactions as of
-
Jan 19, 2023
-
Transactions value $
-
-$5,625
-
Form type
-
4
-
Date filed
-
1/19/2023, 04:19 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
AVEO |
Common Stock |
Disposed to Issuer |
-$5.63K |
-375 |
-50% |
$15.00 |
375 |
Jan 19, 2023 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
AVEO |
Stock Option (Right to Buy) |
Disposed to Issuer |
|
-1.25K |
-100% |
|
0 |
Jan 19, 2023 |
Common Stock |
1.25K |
$25.90 |
Direct |
F2 |
transaction |
AVEO |
Stock Option (Right to Buy) |
Disposed to Issuer |
|
-1.25K |
-100% |
|
0 |
Jan 19, 2023 |
Common Stock |
1.25K |
$15.70 |
Direct |
F2 |
transaction |
AVEO |
Stock Option (Right to Buy) |
Disposed to Issuer |
|
-2.52K |
-100% |
|
0 |
Jan 19, 2023 |
Common Stock |
2.52K |
$16.10 |
Direct |
F2 |
transaction |
AVEO |
Stock Option (Right to Buy) |
Disposed to Issuer |
|
-2K |
-100% |
|
0 |
Jan 19, 2023 |
Common Stock |
2K |
$20.00 |
Direct |
F2 |
transaction |
AVEO |
Stock Option (Right to Buy) |
Disposed to Issuer |
|
-6.4K |
-100% |
|
0 |
Jan 19, 2023 |
Common Stock |
6.4K |
$9.20 |
Direct |
F2 |
transaction |
AVEO |
Stock Option (Right to Buy) |
Disposed to Issuer |
|
-7.79K |
-100% |
|
0 |
Jan 19, 2023 |
Common Stock |
7.79K |
$7.00 |
Direct |
F2 |
transaction |
AVEO |
Stock Option (Right to Buy) |
Disposed to Issuer |
|
-4K |
-100% |
|
0 |
Jan 19, 2023 |
Common Stock |
4K |
$22.70 |
Direct |
F2 |
transaction |
AVEO |
Stock Option (Right to Buy) |
Disposed to Issuer |
|
-4K |
-100% |
|
0 |
Jan 19, 2023 |
Common Stock |
4K |
$7.60 |
Direct |
F2 |
transaction |
AVEO |
Stock Option (Right to Buy) |
Disposed to Issuer |
|
-4K |
-100% |
|
0 |
Jan 19, 2023 |
Common Stock |
4K |
$7.52 |
Direct |
F2 |
transaction |
AVEO |
Stock Option (Right to Buy) |
Disposed to Issuer |
|
-12.5K |
-100% |
|
0 |
Jan 19, 2023 |
Common Stock |
12.5K |
$7.27 |
Direct |
F2 |
transaction |
AVEO |
Stock Option (Right to Buy) |
Disposed to Issuer |
|
-22.5K |
-100% |
|
0 |
Jan 19, 2023 |
Common Stock |
22.5K |
$4.27 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Kenneth Bate is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Explanation of Responses:
Remarks:
On January 19, 2022, pursuant to the Agreement and Plan of Merger (as it may be amended from time to time, referred to as the "Merger Agreement"), by and among LG Chem, Ltd. ("Parent"), Acacia acquisition Sub, Inc. ("Merger Sub") and AVEO Pharmaceuticals, Inc. (the "Company"), dated as of October 18, 2022, Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. Pursuant to the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of the Company's common stock automatically converted into the right to receive $15.00 per share in cash (the "Merger Consideration").